Synergistic Potential of Bone Marrow Mesenchymal Stem Cells and mir181-A Combinational Therapy against Multiple Sclerosis

Researchers proposed a synergistic therapy approach that combines the penetrative targeting capability of bone marrow MSCs (BMSCs) with the immuno-modulatory effects of miR181-a by overexpressing miR181-a to BMSCs through lentivirus packaging system.